Skip to main content

Connect and stay on top of the MedTech regulatory landscape globally.

Pure Global is a trusted global leader and growth partner in the healthcare technology industry. Find regulatory insights from our expert team, AI-powered regulatory news tools, and ways to meet us at upcoming events.

Join Our Community

What you get from signing up

Subscribe to our MedTech newsletter for regulatory insights, early resource access, and practical updates that help you stay ahead.

Regulatory Updates

Be informed on regulatory changes

Stay ahead of the curve with timely updates on the latest regulatory changes impacting the MedTech industry.

Upcoming Events

Find us at future MedTech events

Explore our participation in key conferences, summits, and networking opportunities through our upcoming events list.

Blog

Get insights from industry experts

Gain valuable perspectives from experienced MedTech professionals through our blog articles.

News

Regulatory News

Explore regulatory updates and industry insights designed to help you take your product global.

INVIMA's Specialized Chamber says watches, bracelets, bands, rings, and similar wearables are medical devices when intended for diagnosis or clinical monitoring, but not when limited to wellness without medical claims. In-scope products generally fall under Rule 10 as Class IIa, or Class IIb when specifically intended to monitor vital parameters whose variation may present an immediate danger to life.

ANVISA’s IVD regularization manual (GEVIT, RDC 830/2023) and class I/II materials-notification manual (GEMAT, RDC 751/2022) are orientation texts. Missing documents mean summary refusal. Notification under this class I/II materials route does not require technical analysis for regularization but remains subject to review and audit.

From 1 September 2026, Czech free-sale certificate (FSC) applications go only through ISZP. RZPRO FSC filing ends 31 August 2026. The device must be in EUDAMED status Registered. The fee is 1,000 CZK. RZPRO records are not transferred.

The Digital Omnibus on AI is in force. High-risk rules in Chapter III, Sections 1 to 3, apply from 2 December 2027 for Annex III systems and from 2 August 2028 for Annex I systems, including medical devices and IVDs that meet Article 6(1). Article 50's general application date was not postponed; a separate transition applies to specified Article 50(2) marking.

News

Company News

Browse company milestones, strategic updates, and announcements from Pure Global.

Pure Global has launched a flat-fee pricing model for medical device registration that simplifies global expansion across 13 key markets. With AI-assisted dossier preparation and in-country representation included, manufacturers can easily plan their market access budgets.

Company News

Pure Global has launched AI Builder, a proprietary automation platform that cuts medical device dossier preparation time by up to 75%. The launch introduces a new flat annual pricing model and marks a major step toward on-demand, AI-powered global medical device registration.

Pure Global's new CTO, Ran Chen, brings over a decade of experience in building and scaling machine learning products.

Pure Global is proud to announce its inclusion in the China Business Service Providers (BSP) directory on the International Trade Administration website.

Blog

Recent Blog Posts

Read articles, success stories, and regulatory insights from our global market access experts.

Medical Device Registration Verification 2026: What 15 National Public Data Files Actually Contain

A public register is not a market map. This workpaper names what one row means, which identity fields are filled, and where verification still needs in-country evidence.

Coronary Stent Global Market Access 2026: Class III Almost Everywhere

Coronary stents sit at the highest regulatory tier across major markets. This report maps four US regulatory objects, the PMA supplement lifecycle, eight market-access files, public register evidence, postmarket limits, government fees and a sequencing plan for manufacturers.

Surgical Robot Global Market Access 2026: One Platform, Eight Regulatory Files

Surgical robots do not follow one regulatory class or one reusable filing. This research report maps the public records across eight markets, showing how architecture drives FDA classification, why one platform becomes dozens of registration objects, where clinical evidence controls the schedule, and what government and in-country representation fees actually cost.

ISO 10993-1:2025 Global Transition Guide: How to Build One Biological Evaluation Plan for Seven Regulatory Systems

ISO 10993-1 changed in 2025, but regulators did not change together. This practical guide maps seven regulatory systems and shows how to build one controlled biological-evaluation core with market-specific overlays.

Events

Events

Meet the Pure Global team at upcoming events and discuss your regulatory and market access questions.

Medical Fair Asia 2026 event logo
Trade Fair
Marina Bay Sands, Singapore
Sep 9, 2026

Medical Fair Asia

Medical Fair Asia 2026 is a leading healthcare trade exhibition in Singapore, connecting medical specialists, business executives, and industry professionals across hospital, diagnostic, pharmaceutical, medical equipment, and healthcare supply sectors.

Trade Fair
Düsseldorf, Germany
Nov 16, 2026

MEDICA Trade Fair

One of the largest medical B2B trade fairs globally, showcasing products and services across medical imaging, diagnostics, health IT, and more.

essential industry news delivered to your inbox

Thank you for subscribing!
Oops! Something went wrong while submitting the form.
By subscribing, you agree to our Terms of Use.

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Contact us